References
- Holmes GL, Ben-Ari Y, Zipursky A. The neurobiology and consequences of epilepsy in the developing brain. Pediatr Res. 2001. doi:https://doi.org/10.1203/00006450-200103000-00004.
- Vasudevan C, Levene M. Epidemiology and aetiology of neonatal seizures. Semin Fetal Neonatal Med. 2013. doi:https://doi.org/10.1016/j.siny.2013.05.008.
- Sands TT, McDonough TL. Recent advances in neonatal seizures. Curr Neurol Neurosci Rep. 2016. doi:https://doi.org/10.1007/s11910-016-0694-x.
- Casillas-Espinosa PM, Powell KL, O’Brien TJ. Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy. Epilepsia. 2012. doi:https://doi.org/10.1111/epi.12034.
- Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001. doi:https://doi.org/10.1016/S0301-0082(00)00067-8.
- Tzingounis AV, Wadiche JI. Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat Rev Neurosci. 2007. doi:https://doi.org/10.1038/nrn2274.
- Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann NY Acad Sci. 2008. doi:https://doi.org/10.1196/annals.1418.005.
- Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch Eur J Physiol. 2010. doi:https://doi.org/10.1007/s00424-010-0809-1.
- Beart PM, O’Shea RD. Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol. 2007. doi:https://doi.org/10.1038/sj.bjp.0706949.
- Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis. 2004. doi:https://doi.org/10.1016/j.nbd.2003.12.007.
- Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int. 2007. doi:https://doi.org/10.1016/j.neuint.2007.03.012.
- Coulter DA, Eid T. Astrocytic regulation of glutamate homeostasis in epilepsy. Glia. 2012. doi:https://doi.org/10.1002/glia.22341.
- Bernard PB, Benke TA. Early life seizures: evidence for chronic deficits linked to autism and intellectual disability across species and models. Exp Neurol. 2015. doi:https://doi.org/10.1016/j.expneurol.2014.09.018.
- Falcón-Moya R, Sihra TS, Rodríguez-Moreno A. Kainate receptors: role in epilepsy. Front Mol Neurosci. 2018. doi:https://doi.org/10.3389/fnmol.2018.00217.
- Zhu J, Zheng XY, Zhang HL, et al. Kainic acid-induced neurodegenerative model: potentials and limitations. J Biomed Biotechnol. 2011. doi:https://doi.org/10.1155/2011/457079.
- McKhann GM, Wenzel HJ, Robbins CA, et al. Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience. 2003. doi:https://doi.org/10.1016/S0306-4522(03)00562-1.
- Bernard PB, Castano AM, Beitzel CS, et al. Behavioral changes following a single episode of early-life seizures support the latent development of an autistic phenotype. Epilepsy Behav. 2015. doi:https://doi.org/10.1016/j.yebeh.2015.01.006.
- Moreira JD, De Siqueira LV, Lague VM, et al. Short-term alterations in hippocampal glutamate transport system caused by one-single neonatal seizure episode: Implications on behavioral performance in adulthood. Neurochem Int. 2011. doi:https://doi.org/10.1016/j.neuint.2011.05.008.
- M JR, L HF. Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: Breastmilk and fish are good for you. Annu Rev Cell Dev Biol. 2005.
- Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Heal Aging. 2004.
- Lauritzen L, Hansen HS, Jorgensen MH, et al. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001. doi:https://doi.org/10.1016/S0163-7827(00)00017-5.
- Musto AE, Gjorstrup P, Bazan NG. The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia. 2011. doi:https://doi.org/10.1111/j.1528-1167.2011.03081.x.
- Musto AE, Quebedeaux T, Sfondouris J, et al. The omega-3 fatty acid-derived mediator neuroprotectin D1 (NPD1) limits dentate gyrus hyperexcitablity and seizure susceptibility. Epilepsy Curr. 2012;3.
- Frigerio F, Pasqualini G, Craparotta I, et al. N-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis. Brain. 2018. doi:https://doi.org/10.1093/brain/awy247.
- Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol. 1994. doi:https://doi.org/10.1016/0014-2999(94)90387-5.
- Trépanier MO, Lim J, Lai TKY, et al. Intraperitoneal administration of docosahexaenoic acid for 14days increases serum unesterified DHA and seizure latency in the maximal pentylenetetrazol model. Epilepsy Behav. 2014. doi:https://doi.org/10.1016/j.yebeh.2014.02.020.
- Voskuyl RA, Vreugdenhil M, Kang JX, et al. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol. 1998. doi:https://doi.org/10.1016/S0014-2999(97)01467-2.
- Cysneiros RM, Ferrari D, Arida RM, et al. Qualitative analysis of hippocampal plastic changes in rats with epilepsy supplemented with oral omega-3 fatty acids. Epilepsy Behav. 2010. doi:https://doi.org/10.1016/j.yebeh.2009.11.006.
- Ferrari D, Cysneiros RM, Scorza CA, et al. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav. 2008. doi:https://doi.org/10.1016/j.yebeh.2008.01.001.
- Bromfield E, Dworetzky B, Hurwitz S, et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav. 2008. doi:https://doi.org/10.1016/j.yebeh.2007.09.011.
- Yuen AWC, Sander JW, Fluegel D, et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: A randomized trial. Epilepsy Behav. 2005. doi:https://doi.org/10.1016/j.yebeh.2005.04.014.
- Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia. 2002. doi:https://doi.org/10.1046/j.1528-1157.2002.13601.x.
- Moreira JD, Knorr L, Ganzella M, et al. Omega-3 fatty acids deprivation affects ontogeny of glutamatergic synapses in rats: relevance for behavior alterations. Neurochem Int. 2010. doi:https://doi.org/10.1016/j.neuint.2010.02.010.
- Moreira JD, Knorr L, Thomazi AP, et al. Dietary omega-3 fatty acids attenuate cellular damage after a hippocampal ischemic insult in adult rats. J Nutr Biochem. 2010. doi:https://doi.org/10.1016/j.jnutbio.2009.01.013.
- Cornejo BJ, Mesches MH, Coultrap S, et al. A single episode of neonatal seizures permanently alters glutamatergic synapses. Ann Neurol 2007. doi:https://doi.org/10.1002/ana.21071.
- Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007. doi:https://doi.org/10.1038/nprot.2007.44.
- Bach SA, de Siqueira LV, Müller AP, et al. Dietary omega-3 deficiency reduces BDNF content and activation NMDA receptor and Fyn in dorsal hippocampus: implications on persistence of long-term memory in rats. Nutr Neurosci. 2014;17:186–92 doi:https://doi.org/10.1179/1476830513Y.0000000087.
- Izquierdo LA, Barros DM, Vianna MRM, et al. Molecular pharmacological dissection of short- and long-term memory. Cell Mol Neurobiol. 2002;22(3):269–87. doi:https://doi.org/10.1023/A:1020715800956.
- Izquierdo I, Medina JH. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem. 1997. doi:https://doi.org/10.1006/nlme.1997.3799.
- Berman DR, Liu YQ, Barks J, et al. Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation. Am J Obstet Gynecol. 2010. doi:https://doi.org/10.1016/j.ajog.2010.01.076.
- Thomazeau A, Bosch-Bouju C, Manzoni O, et al. Nutritional n-3 PUFA deficiency abolishes endocannabinoid gating of hippocampal long-term potentiation. Cereb Cortex . 2017. doi:https://doi.org/10.1093/cercor/bhw052.
- Ueda Y, Doi T, Tokumaru J, et al. Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. J Neurochem. 2001. doi:https://doi.org/10.1046/j.1471-4159.2001.00087.x.
- Gegelashvili G, Civenni G, Racagni G, et al. Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes. Neuroreport. 1997. doi:https://doi.org/10.1097/00001756-199612200-00052.
- Duan S, Anderson CM, Stein BA, et al. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci. 1999. doi:https://doi.org/10.1523/jneurosci.19-23-10193.1999.
- Binder DK, Steinhäuser C. Functional changes in astroglial cells in epilepsy. Glia. 2006. doi:https://doi.org/10.1002/glia.20394.
- Seifert G, Carmignoto G, Steinhäuser C. Astrocyte dysfunction in epilepsy. Brain Res Rev. 2010. doi:https://doi.org/10.1016/j.brainresrev.2009.10.004.
- Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci. 2005. doi:https://doi.org/10.1038/nrn1722.
- Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010. doi:https://doi.org/10.1007/s00401-009-0619-8.
- Robel S, Buckingham SC, Boni JL, et al. Reactive astrogliosis causes the development of spontaneous seizures. J Neurosci. 2015. doi:https://doi.org/10.1523/JNEUROSCI.1574-14.2015.
- Ortinski PI, Dong J, Mungenast A, et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci. 2010. doi:https://doi.org/10.1038/nn.2535.
- Robel S, Mori T, Zoubaa S, et al. Conditional deletion of β1-integrin in astroglia causes partial reactive gliosis. Glia. 2009. doi:https://doi.org/10.1002/glia.20876.
- Colangelo AM, Alberghina L, Papa M. Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci Lett. 2014. doi:https://doi.org/10.1016/j.neulet.2014.01.014.
- Cirillo G, Cavaliere C, Bianco MR, et al. Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain. Cell Mol Neurobiol. 2010. doi:https://doi.org/10.1007/s10571-009-9430-2.
- Cirillo G, Bianco MR, Colangelo AM, et al. Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor. Neurobiol Dis. 2011. doi:https://doi.org/10.1016/j.nbd.2010.11.012.
- Cirillo G, Colangelo AM, Bianco MR, et al. BB14, a nerve growth factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury. Biotechnol Adv. 2012. doi:https://doi.org/10.1016/j.biotechadv.2011.05.008.
- Martin RE, Bazan NG. Changing fatty acid content of growth cone lipids prior to synaptogenesis. J Neurochem. 1992. doi:https://doi.org/10.1111/j.1471-4159.1992.tb08906.x.
- Lim S-Y, Doherty JD, McBride K, et al. Lead Exposure and (n-3) fatty acid deficiency during Rat neonatal development affect subsequent Spatial task performance and Olfactory Discrimination. J Nutr. 2005. doi:https://doi.org/10.1093/jn/135.5.1019.
- Lozada LE, Desai A, Kevala K, et al. Perinatal brain Docosahexaenoic acid concentration has a lasting impact on cognition in mice. J Nutr. 2017. doi:https://doi.org/10.3945/jn.117.254607.
- Moriguchi T, Greiner RS, Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem. 2000. doi:https://doi.org/10.1046/j.1471-4159.2000.0752563.x.